From the Nasdaq MarketSite Studio, New to The Street airs TV Host Jane King's interview with Alex Seelenberger, Chief Financial Officer of Vincerx Pharma, Inc. (NASDAQ: VINC) ($VINC). As a clinical-stage biopharmaceutical Company, Vincerx leverages its oncology...
![Biopharmaceutical– Vincerx Pharma, Inc.’s (NASDAQ: VINC) ($VINC) interview with Alex Seelenberger, Chief Financial Officer](https://e7e11d.p3cdn1.secureserver.net/wp-content/uploads/2023/10/maxresdefault-12-1080x675.jpg)